Hyphens Pharma International Limited (SGX:1J5)
0.3250
+0.0050 (1.56%)
At close: Jun 10, 2026
SGXC:1J5 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SGXC:1J5 stock has a consensus rating of "Strong Buy" and an average price target of $0.42. The average 1-year stock price forecast is 29.23% higher than the current stock price, while the lowest is $0.40 (+23.08%) and the highest is $0.43 (+32.31%).
Price Target: $0.42 (+29.23%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SGXC:1J5 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Nov '24 | Mar '25 | Aug '25 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
185.08M
from 177.37M
Increased by 4.35%
Revenue Next Year
199.50M
from 185.08M
Increased by 7.79%
EPS This Year
0.04
from 0.02
Increased by 115.05%
EPS Next Year
0.04
from 0.04
Increased by 8.75%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SGD.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 185.1M | ||
| Avg | 185.1M | ||
| Low | 185.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.3% | ||
| Avg | 4.3% | ||
| Low | 4.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.04 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 115.1% | ||
| Low | - |